Antipsychotically useful quinolizidylidene derivatives of xanthenes,
申请人:SmithKline Corporation
公开号:US04089961A1
公开(公告)日:1978-05-16
Tricyclic quinolizidine derivatives administered internally to an animal host, in therapeutically effective amounts, produce antipsychotic activity essentially free of extrapyramidal symptoms.